Free Trial

10x Genomics (TXG) Insider Trading & Ownership

10x Genomics logo
$13.32 -0.25 (-1.84%)
(As of 11/20/2024 ET)

10x Genomics (NASDAQ:TXG) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.03%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$2.04 M
Get TXG Insider Trade Alerts

Want to know when executives and insiders are buying or selling 10x Genomics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TXG Insider Buying and Selling by Quarter

10x Genomics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/22/2024Benjamin J HindsonInsiderSell4,351$22.53$98,028.03  
8/22/2024Justin J McanearCFOSell2,961$22.53$66,711.33  
8/22/2024Serge SaxonovCEOSell6,749$22.53$152,054.97  
5/22/2024Benjamin J HindsonInsiderSell4,087$24.30$99,314.10  
5/22/2024Justin J McanearCFOSell2,936$24.30$71,344.80  
5/22/2024Serge SaxonovCEOSell4,877$24.30$118,511.10  
My #1 Pre IPO Trade for 2025 – NAME and TICKER (Ad)

One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...

3/4/2024Serge SaxonovCEOSell4,660$44.00$205,040.00  
2/22/2024Benjamin J HindsonInsiderSell2,613$46.34$121,086.42  
2/22/2024Justin J McanearCFOSell1,865$46.34$86,424.10  
2/22/2024Serge SaxonovCEOSell2,821$46.34$130,725.14  
2/9/2024Serge SaxonovCEOSell1,000$49.53$49,530.00  
1/16/2024Serge SaxonovCEOSell4,000$45.24$180,960.00  
12/14/2023Serge SaxonovCEOSell2,000$55.03$110,060.00  
11/24/2023Serge SaxonovCEOSell3,723$43.72$162,769.56  
11/22/2023James WilburInsiderSell3,464$43.34$150,129.76  
11/22/2023Justin J McanearCFOSell1,679$43.34$72,767.86  
11/22/2023Serge SaxonovCEOSell3,757$43.34$162,828.38  
11/20/2023James WilburInsiderSell14,718$42.09$619,480.62  
(Data available from 1/1/2013 forward)

TXG Insider Trading Activity - Frequently Asked Questions

10.03% of 10x Genomics stock is owned by insiders. Learn more on TXG's insider holdings.

The following insiders have sold TXG shares in the last 24 months: Benjamin J Hindson ($1,883,953.50), James Wilbur ($1,213,630.60), John R Stuelpnagel ($548,900.00), Justin J Mcanear ($580,588.40), Mathai Mammen ($1,743,060.00), and Serge Saxonov ($4,819,344.30).

Insiders have sold a total of 221,572 10x Genomics shares in the last 24 months for a total of $10,789,476.80 sold.

10x Genomics Key Executives

  • Dr. Serge Saxonov Ph.D. (Age 47)
    Co-Founder, CEO & Director
    Compensation: $925.05k
  • Dr. Benjamin J. Hindson Ph.D. (Age 49)
    Co-Founder, President, Chief Scientific Officer & Director
    Compensation: $618.32k
  • Mr. Eric S. Whitaker Esq. (Age 57)
    Chief Legal Officer
    Compensation: $615.38k
  • Mr. Michael Schnall-Levin
    Founding Scientist & CTO
  • Ms. Cassie Corneau
    Manager of Investor Relations and Strategic Finance
  • Ms. Rebecca Port
    Chief People Officer
  • Mr. Jens Durruthy
    Associate Director of Product Management


This page (NASDAQ:TXG) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners